A practical approach for using solubility to design cooling crystallisations

Organic Process Research and Development

Volumn 13, Issue 6, 2009, Pages 1315-1321

  Muller, Frans L ^a   Fielding, Mark ^a   Black, Simon ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72449141474     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op9001438     Document Type: Article

References (17)

1. Bonnett, P. E.; Carpenter, K. J.; Dawson, S.; Davey, R. J. Solution crystallisation via a submerged liquid-liquid phase boundary: oiling out. Chem. Commun. 2003, 698-699,. DOI: 10.1039/b212062c.
2. Muller, F. L. On the rheological behaviour of batch crystallisations. Chem. Eng. Res. Dev. 2009, 87, 627-6321.
3. Black, S. N., Jones, H. P. Seed, Cool and Monitor. International Symposium on Industrial Crystallisation (ISIC) 17, Mastricht, the Netherlands, 2008.
4. Black, S. N.; Quigley, K.; Parker, A. Org. Process Res. Dev. 2006, 10, 241-244.
5. Mullin, J. W. Crystallization, 4th ed.; Equation 3.18; Butterworth-Heinemann: Woburn, MA, 2001; p 98, ISBN 0 7506 4833 3.
6. Lewis, G. N.; Randall, M.; Pitzer, K. S.; Brewer, L. Thermodynamics, 2nd ed.; McGraw-Hill: New York, 1961.
7. Granberg, R. A.; Rasmuson, A. C. Solubility of paracetamol in pure solvents. J. Chem. Eng. Data 2000, 44, 1391-1395.
8. Bustamante, P.; Navarro, J.; Romero, S.; Escalera, B. Thermodynamic origin of the solubility profile of drugs showing one or two maxima against the polarity of aqueous and nonaqueous mixtures: Niflumic acid and Caffeine. J. Pharm. Sci. 2002, 91, 874-882.
9. Getsoian, A.; Lodaya, R. M.; Blackburn, A. C. One-solvent polymorph screen of carbamazepine. Int. J. Pharm. 2008, 348, 3-9.
10. Behme, R. J.; Brook, D. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J. Pharm. Sci. 1991, 80, 986-990.
11. Pardillo-Fontdevila, E.; Esquijarosa, J. A.; Nuevas-Paz, L.; Gago-Alvarez, A. G.; Jaurui-Haza, U. Solubility of cefotaxime sodium salt in seven solvents used in the pharmaceutical industry. J. Chem. Eng. Data 1998, 43, 49-50.
12. Jozwiakovski, M. J.; Nguyn, N. T.; Sisco, J. M.; Spancake, C. W. Solubility behaviour of lamivudine crystal forms in recrystallisation solvents. J. Pharm. Sci. 1996, 85, 193-199.
13. Harris, R. K.; Yeung, R. R.; Lamont, R. B.; Lancaster, R. W.; Lynn, S. M.; Staniforth, S. E. Polymorphism in a novel anti-viral agent: Lamivudine. J. Chem. Soc., Perkin Trans. 1997, 2, 2653-2660.
14. Heyranto, R.; Hasan, M.; Abdullah, E; C. Kumoro, A. C. Solubility of stearic acid in various organic solvents and its prediction using non-ideal solution models. Sci. Asia 2007, 33, 469-472.
15. Garzon, L. C.; Martinez, F. Temperature dependence of solubility for ibuprofen in some organic and aqueous solutions. J. Solution Chem. 2004, 33, 1379-1395.
16. Li, X.; Yin, Q.; Chen, W.; Wang, J. Solubility of hydroquinone in different solvents from 276.65 to 345.10 K. J. Chem. Eng. Data 2006, 51, 127-129.
17. Chemical Hazards Response Information System (CHRIS). Hydroquinone; http://www.chrismanual.com/H/HDQ.pdf, 1999.